Search review questions

Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care

Pharmacotherapy + behavioural support vs neither · smoking cessation in hospitalised patients

Quitline referral vs control · smoking cessation in hospitalised patients

Health system telephone counselling vs quitline · smoking cessation in hospitalised patients

Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care

Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care

Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care

Quit at longest · smoking cessation in hospitalised patients

Quit at longest · smoking cessation in hospitalised patients

Quit at longest · smoking cessation in hospitalised patients

Behavioural support ‐ asynchronous** · smoking cessation in hospitalised patients

Behavioural support ‐ synchronous** · smoking cessation in hospitalised patients

Smoking cessation at 6 months to 1 year · People who smoke

Adverse events at 4 weeks to 6‐9 months Assessed by self‐report · People who smoke

Serious adverse events at 4 weeks to 1 year Assessed via self‐report and medical records · People who smoke

Smoking cessation at 6‐12 months · People who smoke cigarettes

Adverse events at 1 week to 6 months Assessed via self‐report · People who smoke cigarettes

Serious adverse events at 1 week to 1 year Assessed via self‐report and medical records · People who smoke cigarettes

Smoking cessation at 6 to 12 months Assessed using biochemical validation · People who smoke

Adverse events at 12 weeks to 6 months Assessed via self‐report · People who smoke

Serious adverse events at 4 weeks to 8 months Assessed via self‐report and medical records · People who smoke

Smoking cessation (at least six months of · people who smoke

Serious adverse events · people who smoke

Dropouts due to treatment · people who smoke

Smoking cessation (at least six months of · people who smoke

Serious adverse events · people who smoke

Dropouts due to treatment · people who smoke

Smoking cessation (at least six months of · people who smoke

Serious adverse events · people who smoke

Dropouts due to treatment · people who smoke

Face‐to‐face behavioral intervention vs minimal or no support (Measured 3 to 6 months with CO‐validated prolonged and continuous abstinence, and self‐reported abstinence) · people who use waterpipe

Varenicline plus behavioral intervention vs placebo plus behavioral intervention ‐ (repeated point prevalence abstinence (not even a puff/chew/session in the last 7 days) at each of weeks 5, 12, and 25 (combined), verified by CO cutoff < 10 ppm) · people who use waterpipe

Bupropion therapy plus behavioral intervention vs behavioral intervention alone (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe

Bupropion therapy plus behavioral support versus self‐help (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe

E‐health interventions · people who use waterpipe

Smoking abstinence at longest · people who smoke tobacco

SAEs · people who smoke tobacco

Neuropsychiatric SAEs · people who smoke tobacco

Cardiac SAEs · people who smoke tobacco

Smoking abstinence at longest · people who smoke tobacco

SAEs · people who smoke tobacco

Neuropsychiatric SAEs · people who smoke tobacco

Cardiac SAEs · people who smoke tobacco

Smoking abstinence at longest · people who smoke tobacco

SAEs · people who smoke tobacco

Neuropsychiatric SAEs · people who smoke tobacco

SAEs (varenicline vs placebo or no medication) · people who smoke tobacco

Cardiac SAEs · people who smoke tobacco

Smoking abstinence at longest · people who smoke tobacco

SAEs · people who smoke tobacco